Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 8;12(12):e0189146.
doi: 10.1371/journal.pone.0189146. eCollection 2017.

Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe

Mufuta Tshimanga  1 , Batsirai Makunike-Chikwinya  2 , Tonderayi Mangwiro  3 , Patricia Tapiwa Gundidza  1 , Pesanai Chatikobo  1 , Vernon Murenje  2 , Amy Herman-Roloff  4 , Peter H Kilmarx  4 , Marrianne Holec  5 , Gerald Gwinji  6 , Owen Mugurungi  6 , Munyaradzi Murwira  7 , Sinokuthemba Xaba  6 , Scott Barnhart  5   8   9 , Caryl Feldacker  5   9
Affiliations

Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe

Mufuta Tshimanga et al. PLoS One. .

Abstract

Methods: We aimed to determine if the adverse event (AE) rate was non-inferior to an AE rate of 2%, a rate considered the global standard of MC safety. Study procedures, AE definitions, and study staff were unchanged from previous PrePex Zimbabwe trials. After PrePex placement and removal, weekly visits assessed wound healing. Men returned on Day 90. Safety was defined as occurrence of moderate and serious clinical AEs. Efficacy was defined as ability to reach the endpoint of complete circumcision.

Results: Among 400 healthy, HIV-positive, consenting adults, median age was 40 years (IQR: 34, 46); 79.5% in WHO stage 2; median CD4 was 336.5c/μl (IQR: 232, 459); 337 (85%) on anti-retroviral therapy. Among 385 (96%) observed completely healed, median days to complete healing was 42 (IQR: 35-49). There was no association between time to healing and CD4 (p = 0.66). Four study-related severe AEs and no moderate AEs were reported: severe/moderate AE rate of 1.0% (95% CI: 0.27% to 2.5). This was non-inferior to 2% AEs (p = 0.0003). All AEs were device displacements resulting in surgical MC and, subsequently, complete healing.

Conclusion: Male circumcision among healthy, HIV-positive men using PrePex is safe and effective. Reducing the barrier of HIV testing while improving counseling for safer sex practices among all MC clients could increase MC uptake and avert more HIV infections.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. CONSORT flow diagram.
See this image and copyright information in PMC

References

    1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet. 2007;369(9562):657–66. - PubMed
    1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56. Epub 2007/02/27. doi: 10.1016/S0140-6736(07)60312-2 . - DOI - PubMed
    1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS medicine. 2005;2(11):e298 doi: 10.1371/journal.pmed.0020298 - DOI - PMC - PubMed
    1. Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS medicine. 2006;3(7):e262 doi: 10.1371/journal.pmed.0030262 - DOI - PMC - PubMed
    1. Reed J, Grund J, Liu Y, Mwandi Z, Howard AA, McNairy ML, et al. Evaluation of loss-to-follow-up and post-operative adverse events in a voluntary medical male circumcision program in Nyanza Province, Kenya. Journal of acquired immune deficiency syndromes (1999). 2015. - PubMed